Multimerin 1 binds factor V and activated factorV with high affinity and inhibits thrombin generation

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH08-05-0307
Issue:2008: 100/6 (Dec) pp. 955-1217
Pages:1058-1067

Multimerin 1 binds factor V and activated factorV with high affinity and inhibits thrombin generation

Samira B. Jeimy1; Nola Fuller1; Subia Tasneem1; Kenneth Segers2; Alan R. Stafford3; Jeffrey I. Weitz3; Rodney M. Camire4; Gerry A. F. Nicolaes2; Catherine P. M. Hayward1
1Department of Pathology and Molecular Medicine, Health Sciences Center, McMaster University, Hamilton, Ontario, Canada; 2Cardiovascular Research Institute, Maastricht Department of Biochemistry, Maastricht University, Maastricht, The Netherlands; 3Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada; 4Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Summary

Multimerin 1 (MMRN1) is a polymeric, factorV (FV) binding protein that is stored in platelet and endothelial cell secretion granules but is undetectable in normal plasma. In human platelet α-granules, FV is stored complexed to MMRN1, predominantly by noncovalent binding interactions. The FV binding site for MMRN1 is located in the light chain, where it overlaps the C1 and C2 domain membrane binding sites essential for activated FV (FVa) procoagulant function. Surface plasmon resonance (SPR), circular dichroism (CD) and thrombin generation assays were used to study the binding of FV and FVa to MMRN1, and the functional consequences. FV and FVa bound MMRN1 with high affinities (KD: 2 and 7 nM, respectively). FV dissociated more slowly from MMRN1 than FVa in SPR experiments, and CD analyses suggested greater conformational changes in mixtures of FV and MMRN1 than in mixtures of FVa and MMRN1. SPR analyses indicated that soluble phosphatidylserine (1,2-Dicaproylsn- glycero-3-phospho-L-serine) competitively inhibited both FV-MMRN1 and FVa-MMRN1 binding. Furthermore, exogenous MMRN1 delayed and reduced thrombin generation by plasma and platelets, and it reduced thrombin generation by preformed FVa. Exogenous MMRN1 also delayed FV activation, triggered by adding tissue factor to plasma, or by adding purified thrombin or factor Xa to purified FV. The high affinity binding of FV to MMRN1 may facilitate the costorage of the two proteins in platelet α-granules. As a consequence, MMRN1 release during platelet activation may limit platelet dependent thrombin generation in vivo.

Keywords

coagulation inhibitors, platelet physiology, Coagulation factors

DOI

http://dx.doi.org/10.1160/TH08-05-0307

You may also be interested in...

1.

Malgorzata Wygrecka1, Ewa Jablonska1, Andreas Guenther2, Klaus T. Preissner1, Philipp Markart2

Thrombosis and Haemostasis 2008 99 3: 494-501

http://dx.doi.org/10.1160/TH07-11-0666

2.

Simone J. H. Wielders, Lisette Ungethüm, Chris P. M. Reutelingsperger, Edouard M. Bevers, Theo Lindhout

Thrombosis and Haemostasis 2007 98 5: 1056-1062

http://dx.doi.org/10.1160/TH07-05-0322

3.

H. Mani (1), G. Rohde (2), G. Stratmann (1), C. Hesse (1), N. Herth (1), S. Schwers (2), E. Perzborn (2), E. Lindhoff-Last (1)

Thrombosis and Haemostasis 2012 108: -

http://dx.doi.org/10.1160/TH11-12-0832



Articles

You've 534 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...